PEP vs STRO · P/E 22, rev $93.92B vs rev $62.0M
PepsiCo Inc (PEP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PEP revenue for 2025-12-27 was $93.92B. Net income was $8.24B. Revenue was up 2.3% from 2024-12-28 to 2025-12-27. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PEP currently screens at market cap $193.55B and trailing P/E 22.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PEP and STRO stock pages for the full models.
Not investment advice.